Third Harmonic Bio to dissolve, delist from Nasdaq, liquidate $5.35 per share

Third Harmonic Bio, Inc.

Voluntary delisting of common stock from Nasdaq effective before market open on July 31, 2025; Form 25 to be filed.
Certificate of dissolution to be filed with Delaware on July 31, 2025; stock transfer books close that day.
Board authorized $5.35 per share liquidation distribution; record date July 31, 2025; first distribution expected in August 2025.
Officer departures: CMO Edward Conner, CAO Julie Person, COO Jennifer Dittman, Chief Non-Clinical Dev Officer Dennis Dean effective at dissolution.
CFO Christopher Murphy receives retention package: $50k/yr base salary for 3 years, $100k bonus at end for continued service.

item 3.01item 3.03item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.